Estimation of Salivary and Serum Lactate Dehydrogenase in Oral Submucous Fibrosis

被引:13
作者
Mishra, Silpiranjan [1 ]
Kritika, C. [3 ]
Bajoria, Atul Anand [1 ]
Choudhury, Priyadarshini [1 ]
Sahoo, Sanjay Kumar [2 ]
Sangamesh, N. C. [1 ]
机构
[1] KIIT Deemed Be Univ, Dept Oral Med & Radiol, Kalinga Inst Dent Sci, Bhubaneswar, Odisha, India
[2] KIIT Deemed Be Univ, Dept Periodont & Implantol, Kalinga Inst Dent Sci, Bhubaneswar, Odisha, India
[3] Thai Moogambigai Dent Coll & Hosp, Dept Oral Med Diag & Radiol, Madras, Tamil Nadu, India
关键词
Lactate dehydrogenase; oral submucous fibrosis; serum and saliva;
D O I
10.4103/jispcd.JISPCD_214_18
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Aim and Objectives: The objective of the present study was to estimate the serum and salivary lactate dehydrogenase (LDH) levels in patients with oral submucous fibrosis (OSMF) and to study the association between serum and salivary LDH levels and mouth opening, frequency of habit, and duration of habit in patients with OSMF. Materials and Methods: Participants were divided into two groups: Group I - case group diagnosed with OSMF and Group II - the control group. Unstimulated whole saliva was collected from all the participants. The International Federation of Clinical Chemistry method was carried out with the help of LDH (P-L) kit (Crest Biosystems, Goa). Collection of blood sample was done under aseptic precautions and processed for LDH. The data were analyzed using SPSS software 2010 (version 19, IBM, Armonk, NY, USA). Descriptive statistics including mean, range, standard deviation, and percentage were used along with unpaired t-test and Pearson's correlation test. Results: All the participants were male and were in the age range of 18-60 years, with a mean age of 28.63 +/- 10.39 years. The mean salivary LDH levels in patients with OSMF were 1057.30 +/- 640.12 mu g/dl and in the control group were 668.25 +/- 498.45 mu g/dl. The mean serum LDH level in patients with OSMF was 408.35 +/- 158.35 mu g/dl as compared to the control group was 313.05 +/- 82.69 mu g/dl. The Pearson's correlation coefficient between serum LDH and frequency of habit, duration of habit, and mouth opening was found to be 0.55, 0.53, and 0.69, respectively. The Pearson's correlation coefficient between salivary LDH and frequency of habit, duration of habit, and mouth opening was found to be 0.33, 0.04, and 0.13, respectively. The Pearson's correlation coefficient between salivary LDH and serum LDH was found to be -0.18. Conclusions: There was a significant increase in the serum and salivary LDH in OSMF patients as compared to controls; the salivary LDH did not seem to correlate with frequency of the habit, duration of the habit, or mouth opening of OSMF patients. However, serum LDH was found to correlate directly with frequency of the habit and mouth opening in OSMF patients. Hence, based on the results of the present study, it can be hypothesized that serum LDH is a better biological marker than salivary LDH in the evaluation of OSMF.
引用
收藏
页码:289 / 295
页数:7
相关论文
共 50 条
  • [41] Association of Blood Groups with Oral Submucous Fibrosis and if any of the Blood Group is Related with an Increased Risk for Oral Submucous Fibrosis
    Siddique, Sobia
    Zaidi, Syed Muhammad Razi
    Maqbool, Shahida
    Insha, Madiha
    Ali, Muhammad Abul Hasan
    Khurshid, Arooj
    PAKISTAN JOURNAL OF MEDICAL & HEALTH SCIENCES, 2021, 15 (10): : 2776 - 2778
  • [42] PTEN and a-SMA Expression and Diagnostic Role in Oral Submucous Fibrosis and Oral Squamous Cell Carcinoma with Concomitant Oral Submucous Fibrosis
    Monteiro, Roshni
    Hallikeri, Kaveri
    Sudhakaran, Archana
    JOMR-JOURNAL OF ORAL & MAXILLOFACIAL RESEARCH, 2021, 12 (01):
  • [43] Evaluation of Salivary Opiorphin, pH and Flow Rate in Oral Submucous Fibrosis - A Case - Control Observational Study
    Varsha, K. S.
    Lakshmi, Krithika C.
    Ganesan, Anuradha
    Kannan, A.
    Aniyan, Yesoda K.
    JOURNAL OF PHARMACY AND BIOALLIED SCIENCES, 2023, 15 : S656 - S660
  • [44] Evaluation of micronutrient status in serum and saliva of oral submucous fibrosis patients: A clinicopathological study
    Shetty, Shishir Ram
    Babu, Subhas
    Kumari, Suchetha
    Shetty, Pushparaja
    Vijay, R.
    Karikal, Arvind
    INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2012, 33 (04) : 224 - 226
  • [45] Drug treatment for oral submucous fibrosis: an update
    Xueru Chen
    Hui Xie
    Jincai Guo
    BMC Oral Health, 23
  • [46] Evaluation of Hematological Profile in Oral Submucous Fibrosis
    Abidullah, Mohammed
    Gaddikeri, Kavitha
    Anjum, Bushra
    Vairagare, Swapneel
    Tarani, Kulkarni
    Seethamsetty, Swetcha
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (02)
  • [47] Drug treatment for oral submucous fibrosis: an update
    Chen, Xueru
    Xie, Hui
    Guo, Jincai
    BMC ORAL HEALTH, 2023, 23 (01)
  • [48] Prognostic potential of AgNORs in oral submucous fibrosis
    Murgod, Sanjay
    Channabasaviah, Girish Hemadal
    Shivamurthy, Dyamenahalli Malleshappa
    Ashok, Lingappa
    Krishnappa, Savita Jangal
    JOURNAL OF INTERNATIONAL SOCIETY OF PREVENTIVE AND COMMUNITY DENTISTRY, 2016, 6 (02) : 167 - 175
  • [49] Oral submucous fibrosis: An overview of a challenging entity
    Gupta, Sonia
    Jawanda, Manveen Kaur
    INDIAN JOURNAL OF DERMATOLOGY VENEREOLOGY & LEPROLOGY, 2021, 87 (06) : 768 - 777
  • [50] Sociodemographic and Clinical Profile of Oral Submucous Fibrosis
    Nitin Deosthale
    Mateen Khursheed
    Samir Choudhary
    Sonali Prabhakar Khadakkar
    Chaitrika Nagwekar
    Harshawardhan More
    Disha Amar Methwani
    Indian Journal of Otolaryngology and Head & Neck Surgery, 2023, 75 : 3373 - 3378